Jonathan Bernstein
Pediatric Hematology-Oncology · Hershey, PANPI 1669565982
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Sanofi at 26.0% of the total. Reporting peaked in 2019 at $58,877 and has fallen 78.0% since, to $12,956 in 2025. Among pediatric hematology-oncology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $882.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$29K
- Bioverativ Therapeutics Inc.$18K
- Biomarin Pharmaceutical Inc.$16K
- Novartis$16K
- Novo Nordisk$11K
- Alnylam Pharmaceuticals Inc.$7K
- plus $15K from 19 others
Across 12 payments — averaging $772.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$9K
What the payments were for
- Consulting fees$42,24538%
- Speaking & faculty fees$49,17144%
- Travel & lodging$14,27213%
- Food & beverage$6,1165%
- Education$3100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 26 | $29,140 |
| Bioverativ Therapeutics Inc. | 13 | $18,253 |
| Biomarin Pharmaceutical Inc. | 14 | $16,255 |
| Novartis | 13 | $15,696 |
| Novo Nordisk | 9 | $10,653 |
| Alnylam Pharmaceuticals Inc. | 4 | $6,952 |
| Octapharma USA, Inc. | 10 | $4,649 |
| Aptevo Therapeutics Inc | 6 | $3,996 |
| Agios Pharmaceuticals, Inc. | 2 | $2,123 |
| Bayer | 2 | $1,102 |
| Bio Products Laboratory USA, Inc. | 4 | $577 |
| Amneal Pharmaceuticals LLC | 1 | $406 |
| ZOLL Medical Corporation | 1 | $400 |
| Tersera Therapeutics LLC | 1 | $393 |
| Shire North American Group Inc | 3 | $344 |
| Servier Pharmaceuticals LLC | 5 | $283 |
| Genentech USA, Inc. | 3 | $262 |
| Genentech, Inc. | 3 | $150 |
| Johnson & Johnson | 1 | $125 |
| Y-mabs Therapeutics, Inc. | 1 | $97 |
| Pfizer | 1 | $91 |
| Sobi, Inc | 1 | $53 |
| Sanofi-aventis U.S. LLC | 1 | $51 |
| CSL Behring | 1 | $43 |
| GSK | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$112,114 in reported general payments places this provider in the 95th percentile of 139 pediatric hematology-oncology providers in Pennsylvania.
See all pediatric hematology-oncology providers in Pennsylvania →
Other pediatric hematology-oncology in Hershey
- Giselle Saulnier ShollerHershey$193K
- Gayle SminkHershey$18K
- Andrew FreibergHershey$9K
- Valerie BrownHershey$5K
- Nidhi ShahHershey$5K
- Rasaq OlaosebikanHershey$601
- Stephan GruppPhiladelphia$390K
- Samuel BlackmanPhiladelphia$265K
- Benjamin Samelson JonesPhiladephia$112K
- Frederico XavierPittsburgh$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.